[HTML][HTML] Reducing stroke risk in atrial fibrillation: adherence to guidelines has improved, but patient persistence with anticoagulant therapy remains suboptimal
Atrial fibrillation (AF) is a significant risk factor for avoidable stroke. Among high-risk patients
with AF, stroke risk can be mitigated using oral anticoagulants (OACs), however reduction is …
with AF, stroke risk can be mitigated using oral anticoagulants (OACs), however reduction is …
Apixaban, dabigatran, and rivaroxaban versus warfarin for stroke prevention in non-valvular atrial fibrillation: a cost-effectiveness analysis
Background and objective Non-valvular atrial fibrillation (NVAF) increases the risk of
systemic thromboembolic events; therefore, anticoagulant treatment with vitamin K …
systemic thromboembolic events; therefore, anticoagulant treatment with vitamin K …
Cost-effectiveness of edoxaban versus rivaroxaban for stroke prevention in patients with nonvalvular atrial fibrillation (NVAF) in the US
JD Miller, X Ye, GM Lenhart, AM Farr… - ClinicoEconomics …, 2016 - Taylor & Francis
Background Understanding the value of new anticoagulation therapies compared with
existing therapies is of paramount importance in today's cost-conscious and efficiency …
existing therapies is of paramount importance in today's cost-conscious and efficiency …
[HTML][HTML] Endoscopic application of polysaccharide powder for hemostasis in anticoagulated pigs (with video)
G Kaehler, C Dutenhoefner, R Magdeburg - Gastrointestinal Endoscopy, 2015 - Elsevier
Background Acute GI bleeding remains a clinical problem of daily importance. Increasing
numbers of patients with compromised coagulation challenge the established methods of …
numbers of patients with compromised coagulation challenge the established methods of …
口服抗凝剂利伐沙班与华法林预防非瓣膜性心房纤维颤动患者血栓栓塞的疗效比较
钟武， 王亮， 陈红生 - 中国老年学杂志, 2016 - cqvip.com
目的比较利伐沙班与华法林非瓣膜性心房纤维颤动(AF) 患者的有效性和安全性.
方法采用CHADS2 评分法纳入122 例评分≥ 2 的AF 患者, 随机分为利伐沙班组和华法林组 …
方法采用CHADS2 评分法纳入122 例评分≥ 2 的AF 患者, 随机分为利伐沙班组和华法林组 …
聚焦解决模式在脑卒中出院患者随访管理中的应用
裴书萍 - 国际护理学杂志, 2016 - cqvip.com
目的: 探讨对脑卒中患者进行聚焦解决模式随访管理的效果. 方法选取我院神经内科2015 年2-6
月收治的脑卒中患者, 分为对照组37 例, 干预组35 例. 对照组实施常规随访模式管理 …
月收治的脑卒中患者, 分为对照组37 例, 干预组35 例. 对照组实施常规随访模式管理 …
[PDF][PDF] Annual stroke costs to health plans among atrial fibrillation patients
M Friedman, M Selim, J Menzin - American Journal of …, 2015 - ajpblive.s3.amazonaws.com
Objectives: To estimate the 1-year stroke-related cost to manage ischemic stroke (IS) and
hemorrhagic stroke (HS) events in a population with atrial fibrillation (AF). Study Design …
hemorrhagic stroke (HS) events in a population with atrial fibrillation (AF). Study Design …
Estimating the inpatient and outpatient costs of atrial fibrillation and associated adverse events
SH Forrester, EB Devine, SD Sullivan - Value in Health, 2014 - valueinhealthjournal.com
Objectives Atrial fibrillation (AF) increases risk of thrombosis (eg, ischemic stroke (IS),
myocardial infarction (MI), systemic embolism (SE)). Conversely, thrombosis prevention …
myocardial infarction (MI), systemic embolism (SE)). Conversely, thrombosis prevention …
Comparison of Long-Term Oral Anticoagulation Therapies Including Newly Approved Reversal Agent for Dabigatran
M DeVine, N Lennartz, M Wolford… - Pharmacy and …, 2016 - digitalcommons.onu.edu
Anticoagulants are a well-known class of agents essential for the prevention of blood clots,
which may further develop into deep vein thrombosis, pulmonary embolism or stroke …
which may further develop into deep vein thrombosis, pulmonary embolism or stroke …
[引用][C] Nouveaux anticoagulants: données actuelles et prise en charge en chirurgie orale
C Authier - 2015 - Université de Nice Sophia Antipolis